Doubrovinskaia & Kaulen et al.: "Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a follow-up study"; report long-term clinical, laboratory and imaging characteristics
by Paul Alexander
of patients with neurological autoimmunity diagnosed in temporal association (≤6 weeks) with SARS-CoV-2 vaccinations.
“Follow-up data were available for 20 cases (CNS demyelinating diseases n=8, inflammatory peripheral neuropathies n=4, VITT n=3, myositis n=2, myasthenia n=1, limbic encephalitis n=1, giant cell arteritis n=1). Following therapy, the overall disability level improved (median modified Rankin Scale at diagnosis 3 vs 1 at follow-up). The condition of two patients worsened despite immunosuppressants possibly related to their autoimmune diagnoses (limbic encephalitis n=1, giant cell arteritis n=1).”